# Neurovalens Ltd. clinical trials: 20 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 20 trials with Neurovalens Ltd. as lead sponsor, 0 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Neurovalens Ltd.: 20 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/company/neurovalens-ltd

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 20
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 20 newest of 20, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| May 2, 2025 | NCT06956118 | Electrical Vestibular Nerve Stimulation (VeNS) as a Treatment for Improving Sleep in Visually Impaired Patients | Neurovalens Ltd. | Not applicable | Completed | Sleep Quality, Quality of Lifte, Non-24 Sleep-Wake Disorder | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06956118) |
| May 2, 2025 | NCT06956105 | Electrical Vestibular Nerve Stimulation (VeNS) as a Treatment for Anxiety in Adolescents | Neurovalens Ltd. | Not applicable | Completed | General Anxiety Disorder | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06956105) |
| June 24, 2024 | NCT06470035 | Electrical Vestibular Nerve Stimulation (VeNS) as a Treatment for Major Depressive Disorder (MDD) | Neurovalens Ltd. | Not applicable | Withdrawn | Major Depressive Disorder \\(MDD, Depressive Disorder, Major | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06470035) |
| September 25, 2023 | NCT06051864 | Electrical Vestibular Nerve Stimulation (VeNS) As a Treatment for Depression | Neurovalens Ltd. | Not applicable | Completed | Depression | 62 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06051864) |
| June 18, 2023 | NCT05907967 | Electrical Vestibular Stimulation (VeNS), Compared to a Sham Control For The Management Of Anxiety | Neurovalens Ltd. | Not applicable | Completed | Anxiety | 83 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05907967) |
| May 6, 2023 | NCT05845658 | Electrical Vestibular Nerve Stimulation (VeNS) as a Treatment for Anxiety: A Randomized Clinical Trial | Neurovalens Ltd. | Not applicable | Completed | Anxiety | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05845658) |
| March 11, 2022 | NCT05275790 | Efficacy of Electrical Vestibular Nerve Stimulation (VeNS) in the Management of Obesity: A Randomized Clinical Trial | Neurovalens Ltd. | Not applicable | Completed | Obesity | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05275790) |
| February 16, 2022 | NCT05242367 | Electrical Vestibular Nerve Stimulation (VeNS) as a Treatment for PTSD | Neurovalens Ltd. | Not applicable | Completed | Post Traumatic Stress Disorder | 383 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05242367) |
| August 11, 2021 | NCT04999709 | Electrical Vestibular Nerve Stimulation (VeNS) as a Treatment for Anxiety | Neurovalens Ltd. | Not applicable | Completed | Anxiety | 74 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04999709) |
| March 5, 2021 | NCT04783883 | Electrical Vestibular Nerve Stimulation (VeNS): A Follow-up Assessment of Long-term Usage | Neurovalens Ltd. | Observational | Completed | Safety Issues | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04783883) |
| March 4, 2021 | NCT04780893 | Electrical Vestibular Nerve Stimulation (VeNS) as a Method of Sleep Management in People With PTSD | Neurovalens Ltd. | Not applicable | Withdrawn | PTSD, Sleep Disturbance, Insomnia | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04780893) |
| October 22, 2020 | NCT04595968 | Electrical Vestibular Nerve Stimulation (VeNS) Compared to Sham Control As a Means of Improving Glycemic Control in Adults with Type 2... | Neurovalens Ltd. | Not applicable | Completed | Type 2 Diabetes | 267 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04595968) |
| July 1, 2020 | NCT04452981 | Electrical Vestibular Nerve Stimulation (VeNS) as a Treatment for Insomnia | Neurovalens Ltd. | Not applicable | Completed | Insomnia, Sleep Disturbance | 153 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04452981) |
| June 29, 2020 | NCT04450550 | Electrical Vestibular Nerve Stimulation (VeNS) in the Management of Parkinson's Disease | Neurovalens Ltd. | Not applicable | Completed | Parkinson Disease | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04450550) |
| June 16, 2020 | NCT04433273 | Electrical Vestibular Stimulation (VeNS): Assessment of AMPK & SIRT1 Following Repeated Usage | Neurovalens Ltd. | Not applicable | Unknown | Overweight and Obesity | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04433273) |
| January 7, 2020 | NCT04219566 | Vestibular Nerve Stimulation to Improve Sleep | Neurovalens Ltd. | Not applicable | Completed | Insomnia, Sleep, Sleep Disorders, Circadian Rhythm | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04219566) |
| November 4, 2019 | NCT04149951 | Effect of VeSTAL Device in Type 2 Diabetes Mellitus | Neurovalens Ltd. | Not applicable | Completed | Type 2 Diabetes, Metabolic Syndrome | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04149951) |
| October 1, 2019 | NCT04110717 | Electrical Vestibular Nerve Stimulation (VeNS) Compared to Sham Control as a Means of Reducing Excess Body Weight | Neurovalens Ltd. | Not applicable | Completed | Overweight, Obesity, Overweight and Obesity, Overweight or Obesity, Metabolic Syndrome | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04110717) |
| August 21, 2018 | NCT03640286 | Vestibular Stimulation to Trigger Adipose Loss (VeSTAL) Clinical Trial | Neurovalens Ltd. | Not applicable | Completed | Obesity | 241 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03640286) |
| May 3, 2017 | NCT03138369 | Vestibular Stimulation to Trigger Adipose Loss Clinical Trial | Neurovalens Ltd. | Not applicable | Terminated | Obesity, Obesity, Abdominal, Metabolic Syndrome, Weight Loss | 22 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03138369) |

## By phase

| Phase | Trials |
| --- | --- |
| Not applicable | 19 |
| Observational | 1 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 16 |
| Withdrawn | 2 |
| Terminated | 1 |
| Unknown | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Obesity | 5 |
| Metabolic Syndrome | 4 |
| Sleep Initiation and Maintenance Disorders | 4 |
| Overweight | 3 |
| Anxiety Disorders | 3 |
| Diabetes Mellitus, Type 2 | 2 |
| Weight Loss | 2 |
| Prediabetic State | 2 |
| Parasomnias | 2 |
| Stress Disorders, Post-Traumatic | 2 |
| Depression | 2 |
| Obesity, Abdominal | 1 |
| Hypercholesterolemia | 1 |
| Sleep Disorders, Circadian Rhythm | 1 |
| Parkinson Disease | 1 |
| Depressive Disorder, Major | 1 |
| Generalized Anxiety Disorder | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Medical billing companies in the United States](https://specstream.ai/data/businesses/medical-billing-companies/united-states)
- [Maternity centers in the United States](https://specstream.ai/data/businesses/maternity-centers/united-states)
- [Manufacturers in the United States](https://specstream.ai/data/businesses/manufacturers/united-states)
- [Logging companies in the United States](https://specstream.ai/data/businesses/logging-companies/united-states)
- [Lighting fixtures and equipment companies in the United States](https://specstream.ai/data/businesses/lighting-fixtures-and-equipment-companies/united-states)
- [Lawn care companies in the United States](https://specstream.ai/data/businesses/lawn-care-companies/united-states)
